This segment encompasses the provision of comprehensive pathology services, including routine and advanced testing across various disciplines. Research and development activities focus on improving diagnostic accuracy and efficiency through the adoption of advanced technologies and methodologies. These include chemical pathology, hematology, histopathology, immunology, serology, and microbiology. The segment serves a broad range of therapeutic areas, impacting patient outcomes through accurate and timely diagnoses. Australian Clinical Labs holds a strong market position in Australia, offering services to both public and private hospitals. Future opportunities lie in expanding service offerings and leveraging technological advancements to enhance diagnostic capabilities. Regulatory compliance and clinical validation are critical aspects of this segment, ensuring the reliability and accuracy of test results. Partnerships with healthcare providers and research institutions are essential for continued growth and innovation.